This is a phase 2 trial to test the safety and use of umbilical cord stem cells (allogeneic umbilical cord derived mesenchymal stem cells: UC-MSC) in a “late stage” of chronic spinal cord injury (>12 months post-injury). If included, the participant will receive an intrathecal injection of either 1) UC-MSC or 2) placebo (no UC-MSC), into the CSF (cerebrospinal fluid) around the spinal cord, once a month for 4 months. The participant will be followed for 12 months.
Traumatic
Type
Details
If included, the participant will receive an intrathecal injection of either 1) UC-MSC or 2) placebo (no UC-MSC), into the CSF (cerebrospinal fluid) around the spinal cord, once a month for 4 months. The participant will be followed for 12 months.
Main benefits
General health
Additional benefits
Arm/hand function
Bladder health/function
Sensory function
Standing/walking/mobility
Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn moreWings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more